NEVVI Medicare utilization intelligence
or

← back

Provider profile

MORON, ABEL MD

Gynecological Oncology · NPI 1033435367 · ARLINGTON, TX

1
Groups
27
Codes · 2024
35,819
Disclosed services

MORON, ABEL is a Gynecological Oncology in ARLINGTON, TX, a member of 1 medical group, who billed 27 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

35,819
disclosed services
27
codes billed to Medicare Part B
Prior year · CY2023 779 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J1756 Injection, iron sucrose, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
J1626 Injection, granisetron hydrochloride, 100 mcg
96413 Administration of chemotherapy into vein, 1 hour or less
96375 Injection of additional new drug or substance into vein
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99459 Pelvic exam
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96372 Injection of drug or substance under skin or into muscle
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
83735 Magnesium level
96415 Administration of chemotherapy into vein, each additional hour
96417 Administration of additional new drug or substance into vein, 1 hour or less
71260 Ct scan of chest with contrast
74177 Ct scan of abdomen and pelvis with contrast
J1200 Injection, diphenhydramine hcl, up to 50 mg
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J7030 Infusion, normal saline solution , 1000 cc
96523 Irrigation of implanted venous access drug delivery device

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.